[
    [
        {
            "time": "",
            "original_text": "中国大陆已有6种疫苗在临床试验 疫苗板块或迎上涨",
            "features": {
                "keywords": [
                    "疫苗",
                    "临床试验",
                    "疫苗板块",
                    "上涨"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中国大陆已有6种疫苗在临床试验 疫苗板块或迎上涨",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "研值担当，价值护航！第14届上市公司价值评选评委阵容亮相！申报系统开放",
            "features": {
                "keywords": [
                    "上市公司",
                    "价值评选",
                    "评委阵容",
                    "申报系统"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "研值担当，价值护航！第14届上市公司价值评选评委阵容亮相！申报系统开放",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 4,
                "Impact": 2,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【民生医药|周报】：疫苗集中采购政策对疫苗价格和量影响很有限，持续关注后疫情时代下“枢纽性”和内需驱动型板块的成长确定性",
            "features": {
                "keywords": [
                    "疫苗",
                    "集中采购",
                    "政策",
                    "价格",
                    "量",
                    "后疫情时代",
                    "枢纽性",
                    "内需驱动",
                    "成长确定性"
                ],
                "sentiment_score": 0.65,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【民生医药|周报】：疫苗集中采购政策对疫苗价格和量影响很有限，持续关注后疫情时代下“枢纽性”和内需驱动型板块的成长确定性",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【药咖君】罕见肺部疾病首款疗法获批；56亿销售额，石药王牌迎来首个对手；豪森拿下首仿；BI、武田、正大天晴、绿叶",
            "features": {
                "keywords": [
                    "罕见病",
                    "肺部疾病",
                    "疗法获批",
                    "石药",
                    "销售额",
                    "首仿",
                    "BI",
                    "武田",
                    "正大天晴",
                    "绿叶"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【药咖君】罕见肺部疾病首款疗法获批；56亿销售额，石药王牌迎来首个对手；豪森拿下首仿；BI、武田、正大天晴、绿叶",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]